Science 37 Holdings Financials

Science 37 Stock Summary

Science 37 competes with FOXO Technologies, Mangoceuticals, Common, Healthcare Triangle, EUDA Health, and HealthStream. Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. Science 37 operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 601 people.

Science 37 Key Financial Ratios

Science Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Science 37's current stock value. Our valuation model uses many indicators to compare Science 37 value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Science 37 competition to find correlations between indicators driving Science 37's intrinsic value. More Info.Science 37 Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Science 37 by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.